Anavex Life Sciences (AVXL)
(Real Time Quote from BATS)
$3.44 USD
+0.05 (1.48%)
Updated Apr 26, 2024 12:42 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
AVXL 3.44 +0.05(1.48%)
Will AVXL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AVXL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AVXL
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal
AVXL: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade
New Strong Buy Stocks for January 31st
Other News for AVXL
Class Action Lawsuit against Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
Commit To Purchase Anavex Life Sciences Corp At $3, Earn 21.5% Annualized Using Options
Largest borrow rate increases among liquid names
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference